TRIL
Trillium Therapeutics

9,804
Loading...
Loading...
Trillium Therapeutics Inc. operates as a biopharmaceutical research and development company. It focuses on the immune system and its regulation. The company specializes in the discovery and development of protein therapeutics, such as monoclonal antibodies, secreted proteins, and peptides. It involves in therapeutic areas, including autoimmune disease, cancer, necrotizing enterocolitis, and transplantation. Trillium Therapeutics Inc. was formerly known as Transplantation Technologies Inc. and changed its name in May 2003. The company was founded in 1996 and is based in Toronto, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Trillium Therapeutics Inc?
What is the 52-week high for Trillium Therapeutics Inc?
What is the 52-week low for Trillium Therapeutics Inc?
What is Trillium Therapeutics Inc stock price today?
What was Trillium Therapeutics Inc stock price yesterday?
What is the PE ratio of Trillium Therapeutics Inc?
What is the Price-to-Book ratio of Trillium Therapeutics Inc?
What is the 50-day moving average of Trillium Therapeutics Inc?

Latest TRIL News

View
No TRIL news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.